Chapter 1.Global Virtual Clinical Trials Market– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.Global Virtual Clinical Trials Market– Executive Summary

2.1. Market Size & Forecast – (2022 – 2026) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-16 Impact Analysis

      2.3.1. Impact during 2022 - 2026

      2.3.2. Impact on Supply – Demand

Chapter 3.Global Virtual Clinical Trials Market– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.Global Virtual Clinical Trials Market - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. Global Virtual Clinical Trials Market- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.Global Virtual Clinical Trials Market– By Study Design

6.1. Observational

6.2. Interventional

6.3. Expanded Access

Chapter 7.Global Virtual Clinical Trials Market– By Indication

7.1. Oncology

7.2. Cardiovascular

7.3. Others

Chapter 8.Global Virtual Clinical Trials Market– By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. The Middle East

8.6. Africa

Chapter 9.Global Virtual Clinical Trials Market– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. ICON, plc

9.2. IQVIA

9.3. Covance

9.4. PRA Health Services

9.5. LEO Innovation Lab

9.6. Parexel International Corporation

9.7. Medidata

9.8. Oracle

9.9. CRF Health